Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interphase cytogenetics in chronic lymphocytic leukemia

J A Garcia-Marco1, C M Price, D Catovsky

  • 1Academic Department of Hematology and Cytogenetics, Royal Marsden Hospital, London, UK.

Cancer Genetics and Cytogenetics
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical use of atracurium in horses undergoing ophthalmic surgery.

Veterinary anaesthesia and analgesia·2017
Same author

Clinical governance and chronic pain: towards a practical solution.

Anaesthesia·2003
Same author

G-overhang dynamics at Tetrahymena telomeres.

The EMBO journal·2001
Same author

How two causes are different from one: the use of (un)conditional information in Simpson's paradox.

Memory & cognition·2001
Same author

Comparison of the caudal and lumbar approaches to the epidural space.

Annals of the rheumatic diseases·2000
Same author

p16INK4A and p19ARF act in overlapping pathways in cellular immortalization.

Nature cell biology·2000

Trisomy 12 and 13q deletions are common in chronic lymphocytic leukemia (CLL). Trisomy 12 correlates with advanced disease, while 13q abnormalities are more frequent, suggesting a new candidate gene in CLL pathogenesis.

Area of Science:

  • Hematology
  • Cancer Genetics
  • Molecular Biology

Background:

  • Chronic lymphocytic leukemia (CLL) is a heterogeneous B-cell malignancy.
  • Chromosomal abnormalities play a crucial role in CLL pathogenesis and progression.
  • Accurate detection of genetic alterations is vital for prognostication.

Purpose of the Study:

  • To determine the incidence of trisomy 12 and 13q12-q14 abnormalities in CLL patients.
  • To investigate the clinical significance and clonal behavior of trisomy 12.
  • To identify potential new genes involved in CLL pathogenesis through 13q deletion analysis.

Main Methods:

  • Conventional cytogenetics and interphase fluorescence in situ hybridization (FISH) were employed.
  • FISH analysis was performed on 580 CLL patients for trisomy 12 detection.

Related Experiment Videos

  • FISH was used to analyze RB1 (13q14) and BRCA2 (13q12.3) loci deletions in subsets of patients.

    • Main Results:

    • Trisomy 12 was detected in 20% of patients by FISH, associated with advanced stage and higher proliferation.
    • Trisomy 12 was found in a proportion of clonal B-cells, indicating a secondary event.
    • 13q deletions, particularly at 13q14 (RB1) and 13q12.3 (BRCA2), were frequent (34% and 80% respectively).
    • Abnormalities of 13q were more frequent than trisomy 12 in CLL.

    Conclusions:

    • Trisomy 12 is a secondary event in CLL progression.
    • 13q abnormalities are common in CLL and may harbor a novel candidate gene at 13q12.3.
    • These genetic alterations provide insights into CLL pathogenesis and potential therapeutic targets.